Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a 13.511\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a.) CCOCCCNC(=O)CCNC(=O)c1cc(OC)c(OC)c(OC)c1
b.) CCCCN(C)C(=O)c1ccc(S(=O)(=O)N2CCOCC2)cc1
c.) O=C(c1ccc2c(c1)OCO2)N1CCCC1
d.) COC(=O)c1ccc(-n2nc(C(F)(F)F)c3c2-c2ccoc2CC3)cc1
Answer: b. CCCCN(C)C(=O)c1ccc(S(=O)(=O)N2CCOCC2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCCN(C)C(=O)c1ccc(S(=O)(=O)N2CCOCC2)cc1
CCCCN(C)C(=O)c1ccc(S(=O)(=O)N2CCOCC2)cc1
N-butyl-N-methyl-4-morpholin-4-ylsulfonylbenzamide